1.Percutaneous Transluminal coronary angioplasty
Hae Jeong JEON ; Hwang Bok LEE ; Jung Hyuk KIM ; In Ho CHA ; Won Hyuck SUH ; Jeong Euy PARK
Journal of the Korean Radiological Society 1986;22(2):180-184
Coronary artery steonosis can be effectively treated by non-operative percutaneous tansluminal coronaryangioplasty(PTCA). We performed PTCA in three patients with coronary artery stenosis, who were referred to thedepartment of radiology, from January to Dec. in 1985. The results were as follows; 1. The locations of coronaryartery stenosis were the proximal anterior descending branch of left coronary artery. 2. The number of stenoticlesions was single without calcium plaque in all three cases. 3. The extent of coronary artery disease is focal,under 2cm in length. 4. PTCA was performed successfully with satisfactory post-dilatation results in all cases. 5.Severe complications such as arterial intimal dissection, acute myocardial infarction, did not occurred. PTCA hasmany advantages over vascular surgery on surgical, economical, and psychological aspects.
Angioplasty, Balloon, Coronary
;
Calcium
;
Constriction, Pathologic
;
Coronary Artery Disease
;
Coronary Stenosis
;
Coronary Vessels
;
Humans
;
Myocardial Infarction
2.Incidence and Predictors of Cataract among People with Type 2 Diabetes Mellitus: Using Secondary Data Analysis from the Ansan Cohort of the Korean Genome and Epidemiology Study
Ihn Sook JEONG ; Eun Joo LEE ; Myo Sung KIM ; Jung Ok YU ; Hae Sun YUN ; Jeong Hee JEONG ; Youn Sun 6 HWANG
Journal of Korean Academy of Nursing 2022;52(1):24-35
Purpose:
This study investigated the incidence and risk factors of cataract in people with diabetes mellitus (DM) using data from Ansan cohort of the Korean Genome and Epidemiology Study (KoGES).
Methods:
Data from a total of 329 patients with type 2 DM without cataract who participated in Ansan cohort of the KoGES from baseline survey (2001–2002) to fifth follow-up visit (2011–2012) were examined.The characteristics of the subjects were analyzed with frequency and percentage, and mean and standard deviation. Cataract incidence was measured as incidence proportion (%). For risk factors of cataract, hazard ratio (HR) and 95% confidence interval (CI) were obtained using the Cox proportional hazard model.
Results:
The cataract incidence over a 10-year follow-up period was 19.1% (15.1 in males and 25.8 in females), and mean age at the incidence of cataract was 63.48 years (61.58 years in males and 65.31 years in females). Age (HR=1.09, 95% CI=1.05–1.13) and HbA1c (HR=1.21, 95% CI=1.07–1.37) or the duration of DM (HR=1.05, 95% CI=1.00–1.09) were found to be independently associated with cataract development.
Conclusion
Cataract development in people with DM is common, and its likelihood increases with age, HbA1c, and the duration of DM. Considering negative effect of cataract on their quality of life and economic burden, nurses should identify people with DM at a higher risk of cataract development, and plan individual eye examination programs to detect cataract development as early as possible.
3.Variations in Nurse Staffing in Adult and Neonatal Intensive Care Units.
Sung Hyun CHO ; Jeong Hae HWANG ; Yun Mi KIM ; Jae Sun KIM
Journal of Korean Academy of Nursing 2006;36(5):691-700
PURPOSE: This study was done to analyze variations in unit staffing and recommend policies to improve nursing staffing levels in intensive care units (ICUs). METHOD: A cross-sectional study design was used, employing survey data from the Health Insurance Review Agency conducted from June-July, 2003. Unitstaffing was measured using two indicators; bed-to-nurse (B/N) ratio (number of beds per nurse), and patient-to-nurse (P/N)ratio (number of average daily patients per nurse). Staffing levels were compared according to hospital and ICU characteristics. RESULT: A total of 414 institutions were operating 569 adult and 86 neonatal ICUs. Tertiary hospitals (n=42) had the lowest mean B/N (0.82) and P/N (0.76) ratios in adult ICUs, followed by general hospitals (B/N: 1.34, P/N: 0.97). Those ratios indicated that a nurse took care of 3 to 5 patients per shift. Neonatal ICUs had worse staffing and had greater variations in staffing ratios than adult ICUs. About 17% of adult and 26% of neonatal ICUs were staffed only by adjunct nurses who had responsibility for a general ward as well as the ICU. CONCLUSION: Stratification of nurse staffing levels and differentiation of ICU utilization fees based on staffing grades are recommended as a policy tool to improve nurse staffing in ICUs.
Analysis of Variance
;
Female
;
Humans
;
Intensive Care Units/economics/*manpower/statistics & numerical data
;
Intensive Care Units, Neonatal/economics/*manpower/statistics & numerical data
;
Nursing Staff, Hospital/economics/*supply & distribution
;
Personnel Staffing and Scheduling/*economics
;
Workload
4.Incidence and Risk Factors of Dyslipidemia after Menopause
Ihn Sook JEONG ; Hae Sun YUN ; Myo Sung KIM ; Youn Sun HWANG
Journal of Korean Academy of Nursing 2022;52(2):214-227
Purpose:
This study was aimed at investigating the incidence and risk factors of dyslipidemia in menopausal women using a Korean community-based longitudinal study.
Methods:
The subjects were 245 postmenopausal women without dyslipidemia who had participated in the Ansan-Ansung cohort study from 2001~2002 (baseline) to 2015~2016 (seventh follow-up visit). The dyslipidemia incidence was measured as incidence proportion (%) and incidence rate per 100 person-years. The predictors of developing dyslipidemia were analyzed with Cox’s proportional hazard model.
Results:
The incidence of new dyslipidemia during the follow-up period was 78.4% (192 patients), and 11.9 per 100 person-years. Mean duration from menopause to developing dyslipidemia was 5.3 years in new dyslipidemia cases. The triglyceride/high density lipoprotein (TG/HDL-C) ratio at baseline (hazard ratio = 2.20; 95% confidence interval = 1.39~3.48) was independently associated with developing dyslipidemia.
Conclusion
Dyslipidemia occurs frequently in postmenopausal women, principally within five years after menopause. Therefore, steps must be taken to prevent dyslipidemia immediately after menopause, particularly in women with a high TG/HDL-C ratio at the start of menopause.
5.Perineal Reconstruction with the Perineal Perforator Based Island Flap.
Hae Min LEE ; Jeong Tae KIM ; Weon Jung HWANG
Journal of the Korean Society of Plastic and Reconstructive Surgeons 2005;32(1):105-109
Perineal area is composed of compact structures of urogenital organs and anus requiring a more sophisticated selection of flap and reconstruction. For achieving better outcome then conventional flap surgery, we use the perineal perforator based island flap for its reconstruction. After locating the perforator by Doppler, the flaps were designed according to the defect or expected vaginal orifice. The flaps were elevated bilaterally as island pattern. Finally defect or neovagina was reconstructed with inconspicious linear scar hidden in the inguinal crease. Five cases were performed with the perineal perforator based island flap. There were 3 cases of vulvar cancer, 1 case of transsexualism, and 1 case of ambiguous genitalia because of congenital adrenal hyperplasia. Operative results were satisfactory with good contouring and less prominent donor scar, when they were compared with other flap reconstructions such as latissimus dorsi perforator flap, groin flap, gracilis myocutaneous flap etc. The perineal perforator based island flap is highly recommended with the advantages of easy flap elevation, good rotation arc, and appropriate flap thickness for contouring. Compared with other conventional flaps, it can be selected as a good option for moderate defect of perineal area.
Adrenal Hyperplasia, Congenital
;
Anal Canal
;
Cicatrix
;
Disorders of Sex Development
;
Groin
;
Humans
;
Myocutaneous Flap
;
Perforator Flap
;
Superficial Back Muscles
;
Tissue Donors
;
Transsexualism
;
Vulvar Neoplasms
6.Clinical study for Patients with Cervical Cancer who had undergone Radical Hysterectomy.
Seong Un JEONG ; Sung Joong CHO ; Jang Hwan KIM ; Nam Woo LEE ; Kyung Jin KIM ; Mi Hae PARK ; In Tak HWANG ; Ji Hak JUNG
Korean Journal of Obstetrics and Gynecology 1999;42(8):1671-1676
OBJECTIVE: The purpose of this study was to analyze the clinical study for patients with cervical cancer who had undergone radical hysterectomy. METHOD: The subjects of this study were one hundred and sixty two patients with cervical cancer who had undergone radical hysterectomy at Eulji Medical College Hospital, Taejon, Korea, from January 1983 to December 1992. We reviewed the medical record retrospectively and analyzed the data. RESULT: The distribution of patients by age was found in the order of 50 decade and 60 decade, 40 decade. Those by the clinical stages were as follows: Stage Ia, 12 cases(7.4%); Stage Ib, 84 cases(51.9%); Stage IIa, 39 cases(24.1%); Stage IIb 27 cases(16.7%). The results of histopathologic type were distributed as follows: squamous cell carcinoma was 91.9%, adenocarcinoma was 4.9% and adenosquamous cell carcinoma was 3.1%. The histologic subtypes of squamous cell carcinoma(149 cases) were as follows: Large cell non-keratinizing type was 75.9%, large cell keratinizing type was 14.8% and small cell type was 1.2%. The frequancy of lymph node metastasis was 22.9% in stage I and 31.8% in stage II. The overall incidence of lymph node metastasis was 26.4%. The frequency of external radiation therapy done after radical hysterectomy was 63.5% in stage I and 75.8% in stage II. The 5-year survival rate was as follows: The Ia was 100%; Stage Ib, 95.2%(4cases); Stage IIa, 87.2%(5cases); Stage IIb, 77.8%(6cases). The incidence of recurrence was 7.4% and recurrent sites were vaginal stump , rectum and pelvic wall. CONCLUSION: The highest incidence of cervix cancer in age distribution was 50 decade(30.9%) and 60 decade(30.9%). The most common clinical stage was Ib(51.9%) and most frequent pathologic type was squamous cell carcinoma(91.9%). The overall incidence of lymph node metastasis was 26.4% and The most common site of recurrence was vaginal stump. The 5-year survival rate was 100% in the stage Ia, 95.2% in the stage Ib, 87.2% in the stage IIa, 77.8% in the stage IIb.
Adenocarcinoma
;
Age Distribution
;
Carcinoma, Squamous Cell
;
Daejeon
;
Humans
;
Hysterectomy*
;
Incidence
;
Korea
;
Lymph Nodes
;
Medical Records
;
Neoplasm Metastasis
;
Rectum
;
Recurrence
;
Retrospective Studies
;
Survival Rate
;
Uterine Cervical Neoplasms*
7.Effects of short-term potassium iodide treatment for thyrotoxicosis due to Graves disease in children and adolescents.
Kyung Uk JEONG ; Hae Sang LEE ; Jin Soon HWANG
Annals of Pediatric Endocrinology & Metabolism 2014;19(4):197-201
PURPOSE: Graves disease is the most common cause of hyperthyroidism in children. Inorganic iodide has been used in combination with antithyroid drugs for more effective normalization of thyroid hormones in some cases of severe thyrotoxicosis. This study aimed to investigate clinical characteristics of childhood thyrotoxicosis and effectiveness of inorganic iodide in the early phase of treatment. METHODS: Sixty-seven pediatric patients (53 girls/14 boys, 11.1+/-3.4 years of age), with newly diagnosed thyrotoxicosis due to Graves disease were recruited. Forty-nine patients were treated with antithyroid drugs alone, while 18 patients were treated with combination of antithyroid drugs and potassium iodide. Initial thyroid function tests and levels of thyroid antibodies were recorded for all patients. Thyroid function tests were repeated 2 and 8 weeks after the initiation of treatment. Measurement thyroid antibodies were done 8 weeks after the initiation of treatment. RESULTS: Mean triiodothyronine and free thyroxine levels were significantly lower (P<0.05) in the group receiving combined therapy of antithyroid drugs and potassium iodide after 2 weeks of treatment compared to the patients receiving antithyroid drugs alone. Eight weeks after the initiation of treatment, thyroid function tests in the two groups did not show significant differences. CONCLUSION: The use of potassium iodide in combination with antithyroid drug is effective for more rapid normalization of thyroid hormones in the early phase treatment of childhood thyrotoxicosis, but larger studies with adequate power are needed in future.
Adolescent*
;
Antibodies
;
Antithyroid Agents
;
Child*
;
Graves Disease*
;
Humans
;
Hyperthyroidism
;
Potassium Iodide*
;
Thyroid Function Tests
;
Thyroid Gland
;
Thyroid Hormones
;
Thyrotoxicosis*
;
Thyroxine
;
Triiodothyronine
8.Multiple Endocrine Neoplasia Type 1 Presenting as Hypoglycemia due to Insulinoma.
Eun Byul KWON ; Hwal Rim JEONG ; Young Seok SHIM ; Hae Sang LEE ; Jin Soon HWANG
Journal of Korean Medical Science 2016;31(6):1003-1006
Multiple endocrine neoplasia (MEN) mutation is an autosomal dominant disorder characterized by the occurrence of parathyroid, pancreatic islet, and anterior pituitary tumors. The incidence of insulinoma in MEN is relatively uncommon, and there have been a few cases of MEN manifested with insulinoma as the first symptom in children. We experienced a 9-year-old girl having a familial MEN1 mutation. She complained of dizziness, occasional palpitation, weakness, hunger, sweating, and generalized tonic-clonic seizure that lasted for 5 minutes early in the morning. At first, she was only diagnosed with insulinoma by abdominal magnetic resonance images of a 1.3 × 1.5 cm mass in the pancreas and high insulin levels in blood of the hepatic vein, but after her father was diagnosed with MEN1. We found she had familial MEN1 mutation, and she recovered hyperinsulinemic hypoglycemia after enucleation of the mass. Therefore, the early genetic identification of MEN1 mutation is considerable for children with at least one manifestation.
Alleles
;
Base Sequence
;
Child
;
DNA Mutational Analysis
;
Female
;
Humans
;
Hypoglycemia/diagnosis
;
Insulin/blood
;
Insulinoma/diagnostic imaging/*pathology
;
Magnetic Resonance Imaging
;
Multiple Endocrine Neoplasia Type 1/*diagnosis/pathology
;
Pancreatic Neoplasms/diagnostic imaging/*pathology
;
Pedigree
;
Polymorphism, Single Nucleotide
;
Proto-Oncogene Proteins/genetics
;
Seizures/complications
9.Endometriosis Detected in Postmenopausal Women Not Receiving Menopausal Hormone Therapy: Two Case Reports.
Tae Hee KIM ; Hae Hyeog LEE ; Soo Ho CHUNG ; Jeong Ja KWAK ; Hwang Shin PARK
The Journal of Korean Society of Menopause 2010;16(3):176-180
Endometriosis is an estrogen dependent disease in reproductive age. Endometriosis is a chronic inflammatory gynecologic disease. Problems associated with endometriosis include dysmenorrhea, dyspareunia, and infertility. Postmenopausal endometriosis is rare; however, postmenopausal endometriosis is infrequently associated with cancer, thus management is most important for gynecologists. We present two cases of endometriosis associated with postmenopausal women who were not receiving menopausal hormone therapy with a retrospective review of the medical records and a brief review of the literature.
Dysmenorrhea
;
Dyspareunia
;
Endometriosis
;
Estrogens
;
Female
;
Genital Diseases, Female
;
Humans
;
Infertility
;
Medical Records
;
Postmenopause
;
Retrospective Studies
10.Glycogenic hepatopathy in a Korean girl with poorly controlled type 1 diabetes mellitus.
Hwal Rim JEONG ; Young Seok SHIM ; Young Bae KIM ; Hae Sang LEE ; Jin Soon HWANG
Annals of Pediatric Endocrinology & Metabolism 2014;19(1):49-52
Glycogenic hepatopathy (GH) is a rare complication of type 1 diabetes mellitus. We report the case of a 13-year-old diabetic female with poorly controlled blood sugar levels who presented with abdominal pain and distention 1 month in duration. She exhibited tender hepatomegaly, an elevated lipid profile, and elevated serum transaminase levels. Her liver histology was consistent with GH. The pathophysiology and/or underlying genetic background of GH remains unclear. The optimum treatment for GH is optimal glycemic control, and the prognosis is favorable. Clinicians should be aware of the possibility of GH and observe the clinical response to optimal glycemic control prior to invasive investigation.
Abdominal Pain
;
Adolescent
;
Blood Glucose
;
Diabetes Mellitus, Type 1*
;
Female
;
Glycogen*
;
Hepatomegaly
;
Humans
;
Liver
;
Prognosis